CLDF Title
Home | Contact Us | Bookmark
 
 
About CLDF Centers of Educational Expertise
 
Back Substance Use Disorder Centers of Educational Expertise  
Banner
 
Lawrence Brown
Dr. Lawrence Brown is the current Chief Executive Officer of START Treatment & Recovery Centers. In his role, Dr. Brown is responsible for all aspects of health care services, oversight of health care professionals, and the conduct of behavioral and bio-medical research.  More
 
  CME and Independent Education  
 
   
 
  Physician Resources 
 
 
  My Publications More  
 
  Alcohol education provided to opioid treatment program patients: results of a nationwide survey.
 
  Barriers to providing health services for HIV/AIDS, hepatitis C virus infection and sexually transmitted infections in substance abuse treatment programs in the United States.
 
  Hepatitis B virus and hepatitis C virus services offered by substance abuse treatment programs in the United States.
 
  Electronic medical record system at an opioid agonist treatment programme: study design, pre-implementation results and post-implementation trends.
 
 
 
  Institution Information
START Treatment and Recovery Centers offer holistic care when treating those with an opioid addiction and co-occurring mental illness to transition patients toward healthy and productive lives. The seven community-based treatment programs use individual and group counseling with medical and behavioral health professionals to treat patients, and some clinics offer short-term, outpatient detoxification and a drug-free chemical dependency program for other non-opiate addictions.
More
 
 
Institution Link  
 
     
  Journal Abstracts  
  Telementoring for hepatitis C treatment in correctional facilities  
     
  Care of Incarcerated Patients  
     
  Primary resistance of hepatitis B virus to nucleoside and nucleotide analogues  
     
  Valproic acid induced acute liver injury resulting in hepatic encephalopathy- a case report and literature review  
     
  Treatment with proton pump inhibitors increases the risk for development of hepatic encephalopathy after implantation of transjugular intrahepatic portosystemic shunt (TIPS)  
     
  Efficacy of Sorafenib for the Treatment of Post-Transplant Hepatocellular Carcinoma Recurrence  
     
  View All Articles  
     
 
                 
 
HBV
Webcasts
Slide Library
Abstract Library
 
HE
Live CME Meetings
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Live CME Meetings
Webcasts
Slide Library
Abstract Library
 
CLDF Follow Us
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Sponsors & Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Hepatology
Substance Use Disorder
     
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2018 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare
providers only. Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.